“Nanoemulsion” gels offer new way to deliver drugs through the skin
Novel materials made with FDA-approved components could deliver large payloads of active ingredients.
Novel materials made with FDA-approved components could deliver large payloads of active ingredients.
System helps machine-learning models glean training information for diagnosing and treating brain conditions.
Compound that knocks out a DNA repair pathway enhances cisplatin treatment and helps prevent drug-resistance.
Selecta Bioscience’s ImmTOR platform could improve gene therapies and prevent some drug side effects.
Through computing, senior and Marshall Scholar Anna Sappington seeks answers to biological questions.
A study of prostate cancer finds “aneuploid” tumors are more likely to be lethal than tumors with normal chromosome numbers.
Researchers apply network theory to HIV protein structure, uncovering a vital link between connectivity and protective immune response.
Machine learning reveals metabolic pathways disrupted by the drugs, offering new targets to combat resistance.
Successfully launched project aims to understand why some injuries result in post-traumatic osteoarthritis while others heal and recover.
MIT/MGH's image-based deep learning model can predict breast cancer up to five years in advance.
Convergence research at MIT and beyond seeks new solutions for global challenges.
Algorithm stitches multiple datasets into a single “panorama,” which could provide new insights for medical and biological studies.
Data-sampling method makes “sketches” of unwieldy biological datasets while still capturing the full diversity of cell types.
Projects will develop new AI technologies that detect and prevent diseases.
Gifts to MIT and Harvard Medical School totaling $9 million will fund independent research on cannabinoid’s influence on brain health and behavior.